COVID-19 Battle: Everest Organics develops Remdesivir API
Mumbai: Pharma major, Everest Organics on Monday said that Remdesivir API has been successfully developed in the R & D facility of the company.
Commenting on the R&D success of EOL team, Dr Sirisha Srikakarlapudi, Director, EOL - New Product Development said, "lt's a moment of utmost satisfaction that with hard work of the past few months by Everest Organics R&D team, we have been able to successfully develop Remdesivir API at lab scale in a short span of time.'
'The development of Remdesivir API by Everest Organics Limited is the outcome of investments we've made in R&D over the period of the last few years, which further helped strengthening technical expertise. Infact we are poised for the development of more products in the Anti-Viral segments in the future"Mr Srikakarlapudi added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd